1.
Relationship between plasminogen activator system and PCOS
纤溶酶原激活系统与多囊卵巢综合征的相关性研究
2.
Clinical significance of the expression of urokinase type plasminogen activator system in endometrial carcinoma
子宫内膜腺癌组织中尿激酶型纤溶酶原激活系统的表达及其临床意义
3.
Effect of Disc Displacement on mRNA Expression of Urokinase Plasminogen Activator and Its Inhibitor-1 in Synovium of TMJ;
颞下颌关节盘前移位后滑膜的纤溶酶原激活剂系统表达
4.
Advances in the Study of Tissue-type Plasminogen Activator and Its Toxicity in the Central Nervous System;
组织型纤溶酶原激活剂与中枢神经系统毒性的研究进展
5.
The relation of plasma plasminogen activator inhibitor activity and coronary heart disease
纤溶酶原激活抑制物活性与冠心病发病关系
6.
The Relationship between the Expression of Yrokinase-type Plasminogen Activator Receptor,and the Infiltration and Metastasis of Gastric Cancer
尿激酶型纤溶酶原激活物受体表达与胃癌浸润和转移过程的关系
7.
Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test
重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
8.
Analysis of the Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Fibrinogen in Patients with Coronary Atherosclerotic Heart Disease
冠心病患者凝血酶激活的纤溶抑制物与纤维蛋白原关系分析
9.
Study on Recombinant Nonglycosylated Urokinase-type Plasminogen Activator;
重组非糖基化尿激酶型纤溶酶原激活剂的研究
10.
recombinant human plasminogen
重组体人纤溶酶原激活质
11.
Relationship between the Changes of Activity of Tissue-Type Plasminogen Activator on Brains and Cerebral Edema in Asphyxia Status of Mice
窒息鼠脑组织型纤溶酶原激活物活性变化与脑水肿的关系
12.
Construction of Bacterial Artificial Chromosome Vectors Containing Human Tissue-type Plasminogen Activator Mutant Gene Specially Expressed in Mammary Gland with Red Recombination System;
利用Red系统构建人组织型纤溶酶原激活剂突变体BAC乳腺特异表达载体
13.
Epidermal growth factor differently modulate activity of urokinase plasminogen activator and plasminogen ac-tivator inhibitor-1 in oral squamous cell carcinoma and metastasis carcinoma cell lines
外源性表皮生长因子对口腔鳞癌细胞系尿激酶型纤溶酶原激活剂及其抑制剂活性的影响
14.
Cloning and Expression of Urokinase Type Plasminogen Activator cDNA
尿激酶型纤溶酶原激活因子cDNA的克隆与原核表达
15.
Plasma Concentrations Changes and Significance of Plasminogen Activator, Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 in Chronic Glomerulonephritis and the Intervenient Research on Them;
慢性肾小球肾炎血浆纤溶酶原激活物及其受体和纤溶酶原激活物抑制剂的变化与干预研究
16.
The Expression of uPA and Endostatin in Human Colorectal Carcinoma and Their Relations to Angiogenesis;
人大肠肿瘤中尿激酶型纤溶酶原激活物和内皮抑素的表达与血管新生的关系
17.
Growth movement of hepatic-stellate-cell-T6 cell line and secreting law of urokinase plasminogen activator
肝星状细胞-T6细胞系生长动态及分泌尿激酶型纤溶酶原激活物规律的研究
18.
DETERMINATION OF THE PLASMINOGEN ACTIVATOR IN THE TONSIL OF CHRONIC TONSILLITIS
慢性扁桃体炎组织中的纤溶酶原激活剂测定